Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-10

Clinical Trial Update: Effectiveness and Tolerability of Eptinezumab

View source ↗

Summary

This clinical trial assesses the effectiveness and tolerability of eptinezumab for migraine, including migraine with aura, migraine without aura, and chronic mi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VYEPTI (eptinezumab)

Snippet

Sponsor: University of Florence | Conditions: Migraine, Migraine With Aura | Status: RECRUITING